Decreased transcription, expression and function of low-density lipoprotein receptor in leukocytes from patients with systemic lupus erythematosus

Autoimmunity

Volumn 42, Issue 4, 2009, Pages 266-268

  Rivas, Liliana ^a   Zabaleta, Mercedes ^a   Toro, Flix ^a   Bianco, Nicols E ^a   De Sanctis, Juan B ^a  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

LDLR; Leukocytes; SLE

Indexed keywords

BINDING PROTEIN; CHOLESTEROL; CYCLOPHOSPHAMIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; STEROID;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROL GROUP; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; LEUKOCYTE; MALE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR DISEASE;

ADULT; AUTOANTIBODIES; BLOTTING, NORTHERN; CHOLESTEROL; CHOLESTEROL, LDL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; LEUKOCYTES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; RECEPTORS, LDL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 70749101073     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930902827959     Document Type: Article

References (11)

1. Trager J, Ward MM. Mortality and causes of death in SLE. Curr Opin Rheumatol 2001;13(5):345-351.
2. Hahn BH, McMahon M. Atherosclerosis and SLE: The role of altered lipids and of autoAB. Lupus 2008;17(5):368-370.
3. McMahon M, Hahn BH. Atherosclerosis and SLE: Mechanistic basis of the association. Curr Opin Immunol 2007;19(6): 633-639.
4. Matsuura E, Hughes GR, Khamashta MA. Oxidation of LDL and its clinical implication. Autoimmun Rev 2008;7(7): 558-566.
5. Lara L, Rivera H, Pérez-P C, Blanca I, Bianco NE, De Sanctis JB. Low density lipoprotein receptor expression and function in human polymorphonuclear leukocytes. Clin Exp Immunol 1997;107:205-212.
6. De Sanctis JB, Blanca I, Radzioch D, Bianco N. Expression and function of low density lipoprotein receptors in CD32- CD16+CD56+ cells: Effect of interleukin 2. Cell Immunol 1996;127:18-29.
7. Stulnig TM, Klocker H, Harwood HJ, Jr, Jürgens G, Schönitzer D, Jarosch E, Huber LA, Amberger A, Wick G. In vivo LDL receptor and HMG-CoA reductase regulation in human lymphocytes and its alterations during aging. Arterioscler Thromb Vasc Biol 1995;15(7):872-878.
8. Raghow R, Yellaturu C, Deng X, Park EA, Elam MB. SREBPs: The crossroads of physiological and pathological lipid homeostasis. Trends Endocrinol Metab 2008;19(2): 65-73.
9. Ferré P, Foufelle F. SREBP-1c transcription factor and lipid homeostasis: Clinical perspective. Horm Res 2007;68(2): 72-82.
10. Roder K, Schweizer M. Retinoic acid-mediated transcription and maturation of SREBP-1c regulates fatty acid synthase via cis-elements responsible for nutritional regulation. Biochem Soc Trans 2007;35(Pt 5):1211-1214.
11. Bennett DJ, Cooke AJ, Edwards AS. Non-steroidal LXR agonists: An emerging therapeutic strategy for the treatment of atherosclerosis. Recent Pat Cardiovasc Drug Discov 2006; 1(1):21-46.